Summit Therapeutics Inc.

NASDAQ: SMMT · Real-Time Price · USD
19.30
-6.91 (-26.36%)
At close: May 30, 2025, 10:44 AM

Summit Therapeutics Statistics

Share Statistics

Summit Therapeutics has 737.68M shares outstanding. The number of shares has increased by 5.08% in one year.

Shares Outstanding 737.68M
Shares Change (YoY) 5.08%
Shares Change (QoQ) 0.07%
Owned by Institutions (%) 12.74%
Shares Floating n/a
Failed to Deliver (FTD) Shares 37,550
FTD / Avg. Volume 0.95%

Short Selling Information

The latest short interest is 25.73M, so 3.46% of the outstanding shares have been sold short.

Short Interest 25.73M
Short % of Shares Out 3.46%
Short % of Float 22.06%
Short Ratio (days to cover) 7.45

Valuation Ratios

The PE ratio is -57.95 and the forward PE ratio is -57.84. Summit Therapeutics's PEG ratio is 0.84.

PE Ratio -57.95
Forward PE -57.84
PS Ratio 0
Forward PS 8.3
PB Ratio 32.99
P/FCF Ratio -90.17
PEG Ratio 0.84
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Summit Therapeutics.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 10.15, with a Debt / Equity ratio of 0.02.

Current Ratio 10.15
Quick Ratio 10.15
Debt / Equity 0.02
Debt / EBITDA -0.03
Debt / FCF -0.05
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee n/a
Profits Per Employee $-1,391,918.24
Employee Count 159
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by 140.02% in the last 52 weeks. The beta is -0.95, so Summit Therapeutics's price volatility has been lower than the market average.

Beta -0.95
52-Week Price Change 140.02%
50-Day Moving Average 23.37
200-Day Moving Average 20.27
Relative Strength Index (RSI) 55.67
Average Volume (20 Days) 3,968,883

Income Statement

Revenue n/a
Gross Profit -15.01M
Operating Income 313K
Net Income -221.31M
EBITDA -212.85M
EBIT -230M
Earnings Per Share (EPS) -0.31
Full Income Statement

Balance Sheet

The company has 104.86M in cash and 7.22M in debt, giving a net cash position of 97.64M.

Cash & Cash Equivalents 104.86M
Total Debt 7.22M
Net Cash 97.64M
Retained Earnings -1.21B
Total Assets 383.82M
Working Capital 335.87M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -142.11M and capital expenditures -139K, giving a free cash flow of -142.25M.

Operating Cash Flow -142.11M
Capital Expenditures -139K
Free Cash Flow -142.25M
FCF Per Share -0.2
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

SMMT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for SMMT is $37.5, which is 43.1% higher than the current price. The consensus rating is "Buy".

Price Target $37.5
Price Target Difference 43.1%
Analyst Consensus Buy
Analyst Count 11
Stock Forecasts

Scores

Altman Z-Score 307.6
Piotroski F-Score 4